|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Safety of bevacizumab-based therapy as first-line treatment of patients with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC): M019390 (SAIL)显示文摘 | Dansin E Mezger J Isla D | 2008 | J Clin Oncol2008，26，： | 1 |
| 2 | Safety and effi-cacy of first-line bevacizumab-based therapy in advanced non-squamous non-small cell lung cancer(SAiL,MO19390):a phase4 study显示文摘 | Crino L Dansin E Garrido P Griesinger F Laskin J Pavlakis N Stroiakovski D Thatcher N Tsai CM Wu YL Zhou C | 2010 | Lancet Oncol2010，11，8： | 1 |
| 3 | Phase Ⅱ combination of gefitinib and docetaxel for advanced or metastatic non small cell lung cancer: clinical results and biological monitoring显示文摘 | Gatineau M Dansin E Chomy F | 2006 | Targ Oncol2006，1，3： | 1 |
| 4 | Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL,M019390) : a phase 4 study显示文摘 | Crino L Dansin E Garrido P | 2010 | Lancet Oncol2010，11，8： | 1 |
| 5 | Bevacizumab in tho- racic oncology: Results and practical aspects显示文摘 | Dansin E Cousin S Lauridant | 2013 | Rev Pneu- mol Clin2013，69，3： | 1 |
| 6 | Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer(SAiL, MO19390):a phase 4 study显示文摘 | Crinò L Dansin E Garrido P | | 0，，08： | 1 |
| 7 | MO19390 (SAiL): Bleeding events in a phase IV study of first-line bevacizumab with chemotherapy in patients with advanced non-squamous NSCLC显示文摘 | Eric Dansin Saverio Cinieri Pilar Garrido Frank Griesinger Dolores Isla Manfred Koehler Martin Kohlhaeufl | 2012 | Lung Cancer2012，，3： | 1 |
| 8 | A phase II study of cisplatin with intravenous and oral vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy with oral vinorelbine and cisplatin for locally advanced non - small cell lung cancer显示文摘 | Lerouge D Riviere A Dansin E | 2014 | BMC Cancer2014，14，： | 1 |
| 9 | Image-guided roboticstereotactic radiation therapy with fiducial-free tumor tracking forlung cancer显示文摘 | Bibault JE Prevost B Dansin E | 2012 | Radiat Oncol2012，247，： | 1 |
| 10 | M019390 (SaiL) Study Group: safety of bevacizumab (Bv)-based therapy as first- line treatment of eligible non-small cell lung cancer (NSCLC) patients (pts)显示文摘 | Pavlakis N Crino L Dansin E | 2008 | Ann Oncol2008，19，： | 1 |
| 11 | Safety and efficacy of first-line bevaeizumab-based therapy in advanced non- squamous non-small-cell lung eaneer (SAIL, MO19390) : a phase 4 study 显示文摘 | Crin6L Dansin E Garrido P et M | 2010 | Lancet Oneol2010，11，8： | 1 |
| 12 | Safety and efficacy of first -linebevacizumab -based therapy in advanced non -small cell lung can cer ( SaiL, M019390) : a phase 4 study 显示文摘 | Crino L Dansin E Garrido P | 2010 | Lancet Oncol2010，11，8： | 1 |
| 13 | Safety and efficacy of first-line bevacizumab-based therapy in advanced non-sqamous non-small-cell lung cancer(SAiL,MO 19390): a phase 4 study显示文摘 | Crino L Dansin E Garrido P | 2010 | Lancet Oncol2010，11，8： | 1 |
| 14 | Bevacizumab in tho-racic oncology: Results and practical aspects显示文摘 | Dansin E Cousin S Lauridant G | 2013 | Rev Pneu-mol Clin2013，69，3： | 1 |
| 15 | Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL,MO19390):a phase 4 study显示文摘 | Crinò L Dansin E Griesinger F | 2010 | Lancet Oncol2010，11，8： | 1 |
| 16 | Safety and efficacy offirst-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer ( SAiL,M019390):a phase 4 study 显示文摘 | Crino L Dansin E Garrido P | 2010 | Lancet Oncol2010，11，8： | 1 |
| 17 | Megestrol acetate versus metronomic cyclophosphamide in patients having exhausted all effective therapies under standard care显示文摘 | Penel N Clisant S Dansin E | 2010 | Br J Cancer2010，102，8： | 1 |
| 18 | Safety and efficacy of first-linebevacizumab-based therapy in advanced non-squamous non-small- cell lung cancer ( SAIL, M019390 ) : a phase 4 study 显示文摘 | Crino L Dansin E Garrido P | 2010 | Lancet Oncol2010，11，8： | 1 |
| 19 | Safety and efficacy of first-line bev- acizumab-based therapy in advanced nonsquamous non small cell lung cancer (SAIL, MO19390): a phase 4 study显示文摘 | Crin6 L Dansin E Garrido P | 2010 | Lancet Oncol2010，11，8： | 1 |
| 20 | Safety and efficacy of first-line bevaeizumab-based therapy in advanced non- squamous non-small-cell lung eaneer (SAIL, MO19390) : a phase 4 study 显示文摘 | Crin6L Dansin E Garrido P et M | 2010 | Lancet Oneol2010，11，8： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员